8 Sept 2026
Life sciences & pharma
Sandoz · Ljubljana, Slovenia
Sandoz plans a US$300 million biosimilar drug-substance facility in Ljubljana, adding disposable fed-batch manufacturing capacity to its European supply network. The project targets operation in 2029; no new-jobs figure was disclosed. Included as a major cross-border investment in medicine supply.
GreenfieldFDI · Switzerland → SloveniaAnnouncedSandoz announcement via EQS / MarketScreener
$300M
Planned capital investment